Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Inhibition of DPP-4 with Vildagliptin Improved Insulin Secretion in Response to Oral as well as Isoglycemic Intravenous Glucose without Numerically Changing the Incretin Effect in Patients with Type 2 Diabetes - Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| Author(s) : Vardarli I , Nauck MA , Kothe LD , Deacon CF , Holst JJ , Schweizer A , Foley JE |
| Ref : J Clinical Endocrinology Metab , 96 :945 , 2011 |
| Abstract : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| ESTHER : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| PubMedSearch : Vardarli_2011_J.Clin.Endocrinol.Metab_96_945 |
| PubMedID: 21239518 |
| Title : Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans - Ahren_2011_Diabetes.Obes.Metab_13_775 |
| Author(s) : Ahren B , Schweizer A , Dejager S , Villhauer EB , Dunning BE , Foley JE |
| Ref : Diabetes Obes Metab , 13 :775 , 2011 |
| Abstract : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| ESTHER : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| PubMedSearch : Ahren_2011_Diabetes.Obes.Metab_13_775 |
| PubMedID: 21507182 |
| Title : An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials - Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| Author(s) : Ligueros-Saylan M , Foley JE , Schweizer A , Couturier A , Kothny W |
| Ref : Diabetes Obes Metab , 12 :495 , 2010 |
| Abstract : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| ESTHER : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| PubMedSearch : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495 |
| PubMedID: 20518805 |
| Title : Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy - Ahren_2010_Diabetes.Care_33_730 |
| Author(s) : Ahren B , Foley JE , Ferrannini E , Matthews DR , Zinman B , Dejager S , Fonseca VA |
| Ref : Diabetes Care , 33 :730 , 2010 |
| Abstract : Ahren_2010_Diabetes.Care_33_730 |
| ESTHER : Ahren_2010_Diabetes.Care_33_730 |
| PubMedSearch : Ahren_2010_Diabetes.Care_33_730 |
| PubMedID: 20067974 |
| Title : Weight neutrality with the DPP-4 inhibitor, vildagliptin: mechanistic basis and clinical experience - Foley_2010_Vasc.Health.Risk.Manag_6_541 |
| Author(s) : Foley JE , Jordan J |
| Ref : Vasc Health Risk Manag , 6 :541 , 2010 |
| Abstract : Foley_2010_Vasc.Health.Risk.Manag_6_541 |
| ESTHER : Foley_2010_Vasc.Health.Risk.Manag_6_541 |
| PubMedSearch : Foley_2010_Vasc.Health.Risk.Manag_6_541 |
| PubMedID: 20730070 |
| Title : Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients - Boschmann_2009_J.Clin.Endocrinol.Metab_94_846 |
| Author(s) : Boschmann M , Engeli S , Dobberstein K , Budziarek P , Strauss A , Boehnke J , Sweep FC , Luft FC , He Y , Foley JE , Jordan J |
| Ref : J Clinical Endocrinology Metab , 94 :846 , 2009 |
| Abstract : Boschmann_2009_J.Clin.Endocrinol.Metab_94_846 |
| ESTHER : Boschmann_2009_J.Clin.Endocrinol.Metab_94_846 |
| PubMedSearch : Boschmann_2009_J.Clin.Endocrinol.Metab_94_846 |
| PubMedID: 19088168 |
| Title : Vildagliptin enhances islet responsiveness to both hyper- and hypoglycemia in patients with type 2 diabetes - Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| Author(s) : Ahren B , Schweizer A , Dejager S , Dunning BE , Nilsson PM , Persson M , Foley JE |
| Ref : J Clinical Endocrinology Metab , 94 :1236 , 2009 |
| Abstract : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| ESTHER : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| PubMedSearch : Ahren_2009_J.Clin.Endocrinol.Metab_94_1236 |
| PubMedID: 19174497 |
| Title : Treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin improves fasting islet-cell function in subjects with type 2 diabetes - D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| Author(s) : D'Alessio DA , Denney AM , Hermiller LM , Prigeon RL , Martin JM , Tharp WG , Saylan ML , He Y , Dunning BE , Foley JE , Pratley RE |
| Ref : J Clinical Endocrinology Metab , 94 :81 , 2009 |
| Abstract : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| ESTHER : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| PubMedSearch : D'Alessio_2009_J.Clin.Endocrinol.Metab_94_81 |
| PubMedID: 18957505 |
| Title : Dipeptidyl peptidase-4 inhibition by vildagliptin and the effect on insulin secretion and action in response to meal ingestion in type 2 diabetes - Dalla_2009_Diabetes.Care_32_14 |
| Author(s) : Dalla Man C , Bock G , Giesler PD , Serra DB , Ligueros Saylan M , Foley JE , Camilleri M , Toffolo G , Cobelli C , Rizza RA , Vella A |
| Ref : Diabetes Care , 32 :14 , 2009 |
| Abstract : Dalla_2009_Diabetes.Care_32_14 |
| ESTHER : Dalla_2009_Diabetes.Care_32_14 |
| PubMedSearch : Dalla_2009_Diabetes.Care_32_14 |
| PubMedID: 18931099 |
| Title : Adverse effects of dipeptidyl peptidases 8 and 9 inhibition in rodents revisited - Burkey_2008_Diabetes.Obes.Metab_10_1057 |
| Author(s) : Burkey BF , Hoffmann PK , Hassiepen U , Trappe J , Juedes M , Foley JE |
| Ref : Diabetes Obes Metab , 10 :1057 , 2008 |
| Abstract : Burkey_2008_Diabetes.Obes.Metab_10_1057 |
| ESTHER : Burkey_2008_Diabetes.Obes.Metab_10_1057 |
| PubMedSearch : Burkey_2008_Diabetes.Obes.Metab_10_1057 |
| PubMedID: 18422675 |
| Title : Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes - Azuma_2008_J.Clin.Endocrinol.Metab_93_459 |
| Author(s) : Azuma K , Radikova Z , Mancino J , Toledo FG , Thomas E , Kangani C , Dalla Man C , Cobelli C , Holst JJ , Deacon CF , He Y , Ligueros-Saylan M , Serra D , Foley JE , Kelley DE |
| Ref : J Clinical Endocrinology Metab , 93 :459 , 2008 |
| Abstract : Azuma_2008_J.Clin.Endocrinol.Metab_93_459 |
| ESTHER : Azuma_2008_J.Clin.Endocrinol.Metab_93_459 |
| PubMedSearch : Azuma_2008_J.Clin.Endocrinol.Metab_93_459 |
| PubMedID: 18042650 |
| Title : The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study - Vella_2008_Clin.Endocrinol.(Oxf)_69_737 |
| Author(s) : Vella A , Bock G , Giesler PD , Burton DB , Serra DB , Saylan ML , Deacon CF , Foley JE , Rizza RA , Camilleri M |
| Ref : Clinical Endocrinology (Oxf) , 69 :737 , 2008 |
| Abstract : Vella_2008_Clin.Endocrinol.(Oxf)_69_737 |
| ESTHER : Vella_2008_Clin.Endocrinol.(Oxf)_69_737 |
| PubMedSearch : Vella_2008_Clin.Endocrinol.(Oxf)_69_737 |
| PubMedID: 18331607 |
| Title : Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial - Pan_2008_Diabet.Med_25_435 |
| Author(s) : Pan C , Yang W , Barona JP , Wang Y , Niggli M , Mohideen P , Foley JE |
| Ref : Diabet Med , 25 :435 , 2008 |
| Abstract : Pan_2008_Diabet.Med_25_435 |
| ESTHER : Pan_2008_Diabet.Med_25_435 |
| PubMedSearch : Pan_2008_Diabet.Med_25_435 |
| PubMedID: 18341596 |
| Title : Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea - Garber_2008_Diabetes.Obes.Metab_10_1047 |
| Author(s) : Garber AJ , Foley JE , Banerji MA , Ebeling P , Gudbjornsdottir S , Camisasca RP , Couturier A , Baron MA |
| Ref : Diabetes Obes Metab , 10 :1047 , 2008 |
| Abstract : Garber_2008_Diabetes.Obes.Metab_10_1047 |
| ESTHER : Garber_2008_Diabetes.Obes.Metab_10_1047 |
| PubMedSearch : Garber_2008_Diabetes.Obes.Metab_10_1047 |
| PubMedID: 18284434 |
| Title : The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients - Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| Author(s) : Balas B , Baig MR , Watson C , Dunning BE , Ligueros-Saylan M , Wang Y , He YL , Darland C , Holst JJ , Deacon CF , Cusi K , Mari A , Foley JE , DeFronzo RA |
| Ref : J Clinical Endocrinology Metab , 92 :1249 , 2007 |
| Abstract : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| ESTHER : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| PubMedSearch : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| PubMedID: 17244786 |
| Title : Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes - Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| Author(s) : Mari A , Sallas WM , He YL , Watson C , Ligueros-Saylan M , Dunning BE , Deacon CF , Holst JJ , Foley JE |
| Ref : J Clinical Endocrinology Metab , 90 :4888 , 2005 |
| Abstract : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| ESTHER : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| PubMedSearch : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| PubMedID: 15886245 |
| Title : Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year - Ahren_2005_Diabetes.Care_28_1936 |
| Author(s) : Ahren B , Pacini G , Foley JE , Schweizer A |
| Ref : Diabetes Care , 28 :1936 , 2005 |
| Abstract : Ahren_2005_Diabetes.Care_28_1936 |
| ESTHER : Ahren_2005_Diabetes.Care_28_1936 |
| PubMedSearch : Ahren_2005_Diabetes.Care_28_1936 |
| PubMedID: 16043735 |